JD Health International
JD Health International Inc. is a Chinese healthcare tech enterprise operating an integrated online healthcare and pharmacy platform, spun out from retail giant JD.com. The company provides a broad range of products and services, including direct-to-consumer pharmaceutical retail, wellness products, medical devices, online medical consultations, and health management programs. Its primary revenue drivers stem from the direct sales of prescription and over-the-counter medications and health products, as well as marketplace commissions from third-party merchants and healthcare service providers. JD Health holds a leading market position within China's rapidly expanding digital health and pharmaceutical e-commerce industry. Its primary end market encompasses consumers, healthcare providers, and pharmaceutical manufacturers across mainland China. The company's operational headquarters are located in Beijing, China, with corporate registration in the Cayman Islands. JD Health International is publicly listed on the Hong Kong Stock Exchange.
35 of the funds FundTelligence covers report a position in JD Health International.
- Legal name
- JD Health International Inc
- Sector
- Health Care
- Country
- China
- Funds holding it
- 35
Funds holding JD Health International
- Nordea Emerging Markets Sustainable Enhanced — Nordea Funds · 0.4 % (full portfolio disclosed, September 2026)
- Nordea Emerging Markets Enhanced — Nordea Funds · 0.27 % (full portfolio disclosed, September 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.26 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Bærekraft — Handelsbanken · 0.16 % (full portfolio disclosed, October 2026)
- Nordea Bæredygtige Aktier — Nordea Funds · 0.12 % (full portfolio disclosed, September 2026)
- Nordea Global Sustainable Enhanced — Nordea Funds · 0.11 % (full portfolio disclosed, September 2026)
- Nordea Bærekraftige Aksjer Global — Nordea Funds · 0.11 % (full portfolio disclosed, September 2026)
- Danske Invest Global Emerging Markets Index Restricted — Danske Invest · 0.08 % (full portfolio disclosed, July 2026)
Showing the 8 largest of 35 funds holding it.